Advertisement
Research Article| Volume 30, ISSUE 10, P985-1007, November 15, 1991

Download started.

Ok

Expression of the dopamine D2 receptor gene in brain

  • James H. Meador-Woodruff
    Correspondence
    Address reprint requests to James H. Meador-Woodruff, M.D., Department of Psychiatry, Mental Health Research Institute, University of Michigan Medical Center, 205 Zina Pitcher Place, Ann Arbor, MI 48109-0720.
    Footnotes
    Affiliations
    From the Department of Psychiatry, Mental Health Research Institute, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    Search for articles by this author
  • Alfred Mansour
    Footnotes
    Affiliations
    From the Department of Psychiatry, Mental Health Research Institute, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    Search for articles by this author
  • Author Footnotes
    1 The authors would like to acknowledge the intellectual support and continual encouragement of Drs. Huda Akil and Stanley J. Watson Jr. of the University of Michigan. Dr. Meador-Woodruff is the recipient of a ADAMHA Level I Research Scientist Development Award (1K01 MH00818), and was supported by the American Psychiatric Association/Lilly Psychiatric Fellowship during the first year of these studies.
DOI:https://doi.org/10.1016/0006-3223(91)90120-B
Expression of the dopamine D2 receptor gene in brain
Previous ArticleAnxiogenic effects of m-CPP in patients with panic disorder: Comparison to caffeine's anxiogenic effects
Next ArticleIncidence of hypercortisolism and dexamethasone resistance increases with age among wild baboons
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The cloning of the dopamine (DA) D2 receptor now permits the characterization and regulation of D2 messenger RNA (mRNA) in the brain. In this article, the authors describe their studies delineating the distribution of D2 receptor mRNA in the rodent and primate brain, and compare the distribution of message to D2 receptor binding sites. The effects of chronic DA agonist and antagonist treatment on D2 receptor mRNA are also presented, and provide insights into receptor regulation. Finally, the autoreceptor role of D2 receptors located in the midbrain is examined with a combination of 6-hydroxydopamine lesions and anatomic colocalization studies with tyrosine hydroxylase. These preclinical results provide a framework for subsequent investigation into the nature of D2 receptor gene expression in postmortem brains from patients with disorders putatively associated with dopaminergic dysfunction, especially schizophrenia. They also lay the groundwork for a more profound understanding of DA neurocircuitry by combining molecular biological and traditional anatomical techniques.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Berman K.F.
        • Illowsky B.P.
        • Weinberger D.R.
        Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity.
        Arch Gen Psychiatry. 1988; 45: 616-622
        • Birnberg N.
        • Lissitsky J.
        • Hinman M.
        Glucocorticoids regulate pro-opiomelanocortin gene expression at the level of transcription and secretion.
        in: Proc Natl Acad Sci USA. 80. 1983: 6982-6986
        • Bouthenet M.-L.
        • Martres M.P.
        • Sales N.
        • Schwartz J.C.
        A detailed mapping of dopamine D2 receptors in rat central nervous system by autoradiography with [125I] iodosulpride.
        Neuroscience. 1987; 20: 117-155
        • Boyson S.J.
        • McGonigle P.
        • Molinoff P.B.
        Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.
        J Neurosci. 1986; 6: 3177-3188
        • Brown F.
        • Campbell W.
        • Mitchell P.J.
        • Randall K.
        Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis.
        Br J Pharmacol. 1985; 84: 853-860
        • Brown W.A.
        • Laughren T.
        Low serum prolactin and early relapse following neuroleptic withdrawal.
        Am J Psychiatry. 1981; 138: 237-239
        • Bunzow J.R.
        • van Tol H.H.M.
        • Grandy D.K.
        • et al.
        Cloning and expression of a rat D2 dopamine receptor cDNA.
        Nature. 1988; 336: 783-787
        • Burt D.R.
        • Creese I.
        • Snyder S.H.
        Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain.
        Science. 1977; 196: 326-328
        • Charuchinda C.P.
        • Supavilai P.
        • Karobath M.
        • Palacios J.M.
        Dopamine D2 receptors in the rat brain: Autoradiographic visualization using a high affinity selective agonist ligand.
        J Neurosci. 1987; 7: 1352-1360
        • Chio C.L.
        • Hess G.F.
        • Graham R.S.
        • Huff R.M.
        A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus.
        Nature. 1990; 343: 266-269
        • Chipkin R.E.
        • McQuade R.D.
        • Iorio L.C.
        D1 and D2 dopamine binding site up regulation and apomorphine-induced stereotypy.
        Pharmacol Biochem Behav. 1987; 28: 477-482
        • Chirgwin J.M.
        • Przybyla A.E.
        • MacDonald R.J.
        • Rutter W.J.
        Isolation of biologically active ribonucleic acids from sources enriched for ribonucleases.
        Biochemistry. 1979; 18: 5294-5299
        • Coirini H.
        • Schumacher M.
        • Angulo J.A.
        • McEwen B.S.
        Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.
        Eur J Pharmacol. 1990; 186: 369-371
        • Cooper J.R.
        • Bloom F.E.
        • Roth R.H.
        The Biochemical Basis of Neuropharmacology.
        5th ed. Oxford University Press, New York1986
        • Creese I.
        • Burt I.R.
        • Snyder S.H.
        Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
        Science. 1976; 192: 481-483
        • Cross A.J.
        • Crow T.J.
        • Owen F.
        3H-Flupenthixol binding in postmortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors.
        Psychopharmacology. 1981; 74: 122-124
        • Dal Toso R.
        • Sommer B.
        • Ewert M.
        • et al.
        The dopamine D2 receptor: two molecular forms generated by alternative splicing.
        EMBO J. 1989; 8: 4025-4034
        • Dawson T.M.
        • Barone P.
        • Sidhu A.
        • Wamsley J.K.
        • Chase T.N.
        The D1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand.
        Neuroscience. 1988; 26: 83-100
        • Dearry A.
        • Grinrich J.A.
        • Falardeau P.
        • Fremeau R.T.
        • Bates M.D.
        • Caron M.G.
        Molecular cloning and expression of the gene for a human D1 dopamine receptor.
        Nature. 1990; 347: 72-76
        • Emorine L.J.
        • Marullo S.
        • Delavier-Klutchko C.
        • et al.
        Structure of the gene for human β2-adrenergic receptor: Expression and promoter characterization.
        in: Proc Natl Acad Sci USA. 84. 1987: 6995-6999
        • Ettigi P.
        • Nair N.P.V.
        • Lal S.
        • Cervantes P.
        • Guyda H.
        Effect of apormorphine on growth hormone and prolactin secretion in schizophrenic patients, with and without oral dyskinesia, withdrawn from chronic neuroleptic therapy.
        J Neurol Neurosurg Psychiatry. 1976; 39: 870-876
        • Farde L.
        • Wiesel F.-A.
        • Stone-Elander S.
        • et al.
        D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A position emission tomography study with [11C] raclopride.
        Arch Gen Psychiatry. 1990; 47: 213-219
        • Giros B.
        • Sokoloff P.
        • Martres M.-P.
        • Riou J.-F.
        • Emorine L.J.
        • Schwartz J.-C.
        Alternative splicing directs the expression of two D2 dopamine receptor isoforms.
        Nature. 1989; 342: 923-926
        • Grandy D.K.
        • Marchionni M.A.
        • Makam H.
        • et al.
        Cloning of the cDNA and gene for a human D2 dopamine receptor.
        in: Proc Natl Acad Sci USA. 86. 1989: 9762-9766
        • Herman J.P.
        • Shafer M.K.-H.
        • Young E.A.
        • et al.
        Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis.
        J Neurosci. 1989; 9: 3072-3082
        • Jaskiw G.
        • Kleinman J.
        Postmortem neurochemistry studies in schizophrenia.
        in: Schulz S.C. Tamminga C.A. Schizophrenia: Scientific Progress. Oxford University Press, New York1989: 264-273
        • Johnstone E.C.
        • Crow T.J.
        • Mashiter K.
        Anterior pituitary hormone secretion in chronic schizophrenia—An approach to neurohumoral mechanisms.
        Psychol Med. 1977; 7: 223-228
        • Kleinman J.E.
        • Weinberger D.R.
        • Rogol A.D.
        • et al.
        Plasma prolactin concentrations and psychopathology in chronic schizophrenia.
        Arch Gen Psychiatry. 1982; 39: 655-657
        • Lee T.
        • Seeman P.
        Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
        Am J Psychiatry. 1980; 137: 191-197
        • Mackay A.V.P.
        • Iverson L.L.
        • Rossor M.
        • et al.
        Increased brain dopamine and dopamine receptors in schizophrenia.
        Arch Gen Psychiatry. 1982; 39: 991-997
        • MacLennon A.J.
        • Atmadja S.
        • Lee N.
        • Fibiger H.C.
        Chronic haloperidol administration increases the density of D2 dopamine receptors in the medial prefrontal cortex of the rat.
        Psychopharmacology. 1988; 95: 255-257
        • Mansour A.
        • Meador-Woodruff J.H.
        • Bunzow J.R.
        • Civelli O.
        • Akil H.
        • Watson S.L.
        Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis.
        J Neurosci. 1990; 10: 2587-2600
        • Mansour A.
        • Meador-Woodruff J.H.
        • Camp D.M.
        • et al.
        The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
        in: Quirion R. Jhamandas K. Gianoulakis C. The International Narcotics Research Conference (INRC) '89. Liss, New York1990: 230-277
        • Martinot J.-L.
        • Peron-Megnan P.
        • Huret J.-D.
        • et al.
        Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br] bromospiperone in untreated schizophrenia patients.
        Am J Psychiatry. 1990; 147: 44-50
        • Meador-Woodruff J.H.
        • Mansour A.
        • Bunzow J.R.
        • van Tol H.H.M.
        • Watson S.J.
        • Civelli O.
        Distribution of D2 dopamine receptor mRNA in rat brain.
        in: Proc Natl Acad Sci USA. 86. 1989: 7625-7628
        • Meltzer H.Y.
        • Sachar E.J.
        • Frantz A.G.
        Serum prolactin levels in unmedicated schizophrenic patients.
        Arch Gen Psychiatry. 1974; 31: 564-569
        • Mengod G.
        • Martinez-Mir M.I.
        • Vilaro M.T.
        • Palacios J.M.
        Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry.
        in: Proc Natl Acad Sci USA. 86. 1989: 8560-8564
        • Monsma F.J.
        • McVittie L.D.
        • Gerfen C.R.
        • Mahan L.C.
        • Sibley D.R.
        Multiple D2 dopamine receptors produced by alternative RNA splicing.
        Nature. 1989; 342: 926-929
        • Monsma F.J.
        • Mahan L.C.
        • McVittie L.D.
        • Gerfen C.R.
        • Sibley D.R.
        Molecular cloning and expression of a D1 dopamine receptor linked to adenlyl cyclase activation.
        in: Proc Natl Acad Sci USA. 87. 1990: 6723-6727
        • Najlerahim A.
        • Barton A.J.L.
        • Harrison P.J.
        • Hefferman J.
        • Pearson R.C.A.
        Messenger RNA encoding the D2 dopaminergic receptor detected by in situ hybridization histochemistry in rat brain.
        FEBS Lett. 1989; 255: 335-339
        • O'Dowd B.F.
        • Lefkowitz R.J.
        • Caron M.G.
        Structure of the adrenergic and related receptors.
        Annu Rev Neurosci. 1989; 12: 67-83
        • Rao D.D.
        • McKelvy J.
        • Kebabian J.
        • MacKenzie R.G.
        Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction.
        FEBS Lett. 1990; 263: 18-22
        • Reisine T.D.
        • Nagy J.I.
        • Beaumont K.
        • Fibiger H.C.
        • Yamamura H.I.
        The localization of receptor binding sites in the substantia nigra and striatum of the rat.
        Brain Res. 1979; 177: 241-252
        • Richfield E.K.
        • Young A.B.
        • Penney J.B.
        Comparative distribution of dopamine D1 and D2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys.
        J Comp Neurol. 1987; 262: 446-463
        • Rinieris P.
        • Markianos M.
        • Hatzimanouis J.
        • Stefanis C.
        A psychoendocrine study in male paranoid schizophrenics with delusional ideas of homosexual content.
        Acta Psychiatr Scand. 1985; 72: 309-314
        • Rotrosen J.
        • Angrist B.
        • Gershan S.
        • et al.
        Neuroendocrine effects of apomorphine: Characterization of response patterns and application to schizophrenia research.
        Br J Psychiatry. 1979; 135: 444-456
        • Seeman P.
        • Lee T.
        • Chau-Wong M.
        • Wong K.
        Antipsychotic drug doses and neuroleptic/dopamine receptors.
        Nature. 1976; 261: 717-719
        • Seeman P.
        • Ulpian C.
        • Bergeron C.
        • et al.
        Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
        Science. 1984; 225: 728-731
        • Seeman P.
        • Bzowej N.H.
        • Guan H.C.
        • et al.
        Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's diseases.
        Neuropsychopharmacology. 1987; 1: 5-15
        • Selbie L.A.
        • Hayes G.
        • Shine J.
        The major dopamine D2 receptor: Molecular analysis of the human D2A subtype.
        DNA. 1989; 8: 683-689
        • Snyder S.H.
        The dopamine hypothesis in schizophrenia: Focus on the dopamine receptor.
        Am J Psychiatry. 1976; 133: 197-202
        • Sokoloff P.
        • Giros B.
        • Martres M.-P.
        • Bouthenet M.-L.
        • Schwartz J.-C.
        Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
        Nature. 1990; 347: 146-151
        • Srivastava L.K.
        • Morency M.A.
        • Bajwa S.B.
        • Mishra R.K.
        Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.
        J Mol Neurosci. 1990; 2: 155-161
        • Stoof J.C.
        • De Boer T.
        • Sminia P.
        • Mulder A.H.
        Stimulation of D2 dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gama-aminobutyric acid, glutamate, or serotonin.
        Eur J Pharmacol. 1982; 84: 211-214
        • Sunahara R.K.
        • Niznik H.B.
        • Weiner D.M.
        • et al.
        Human dopamine D1 receptor encoded by an intronless gene on chromosome 5.
        Nature. 1990; 347: 80-83
        • Tamminga C.A.
        • Smith R.C.
        • Pandey G.
        • Frohman L.A.
        • Davis J.M.
        A neuroendocrine study of supersensitivity in tardive dyskinesia.
        Arch Gen Psychiatry. 1977; 34: 1199-1203
        • van Tol H.H.M.
        • Riva M.
        • Civelli O.
        • Creese I.
        Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level.
        Neurosci Lett. 1990; 111: 303-308
        • Wamsley J.K.
        • Gehlert D.R.
        • Filloux F.M.
        • Dawson T.M.
        Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain.
        J Chem Neuroanat. 1989; 2: 119-137
        • Weinberger D.R.
        • Berman K.F.
        • Illowsky B.P.
        Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.
        Arch Gen Psychiatry. 1988; 45: 609-615
        • Weiner D.M.
        • Brann M.R.
        The distribution of a dopamine D2 receptor mRNA in rat brain.
        FEBS Lett. 1989; 253: 207-213
        • White F.J.
        • Wang R.J.
        Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.
        Science. 1983; 221: 1054-1057
        • Wong D.F.
        • Wagner H.N.
        • Tune L.E.
        • et al.
        Position emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
        Science. 1986; 234: 1558-1563
        • Wood W.I.
        • Gitschier J.
        • Lasky L.A.
        • Lawn R.M.
        Base composition-independent hybridization in tetramethylammonium chloride: A method for oligonucleotide screening of highly complex gene libraries.
        Biochemistry. 1984; 82: 1585-1588
        • Zhou Q.-Y.
        • Grandy D.K.
        • Thambi L.
        • et al.
        Cloning and expression of human and rat D1 dopamine receptors.
        Nature. 1990; 347: 76-80

      Article info

      Publication history

      Received in revised form: July 9, 1991
      Received: May 22, 1991

      Footnotes

      ☆Recipient of 1991 A.E. Bennett Award for Research.

      ☆☆This work was also supported in part by grants from the National Institute for Mental Health (MH422251, MH15794, and MH45614), the National Alliance for the Mentally Ill (NAMI), the Lucille P. Markey Charitable Trust, the Theophile Raphael Fund at the University of Michigan, and the National Alliance for Research on Schizophrenia and Depression (NARSAD) to Drs. Akil and Watson.

      Identification

      DOI: https://doi.org/10.1016/0006-3223(91)90120-B

      Copyright

      © 1991 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX